Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where José Carlos Fernández-García is active.

Publication


Featured researches published by José Carlos Fernández-García.


PLOS ONE | 2012

Executive functions profile in extreme eating/weight conditions: from anorexia nervosa to obesity

Ana B. Fagundo; Rafael de la Torre; Susana Jiménez-Murcia; Zaida Agüera; Roser Granero; Salomé Tárrega; Cristina Botella; Rosa M. Baños; José Manuel Fernández-Real; Roser Rodríguez; Laura Forcano; Gema Frühbeck; Javier Gómez-Ambrosi; Francisco J. Tinahones; José Carlos Fernández-García; Felipe F. Casanueva; Fernando Fernández-Aranda

Background Extreme weight conditions (EWC) groups along a continuum may share some biological risk factors and intermediate neurocognitive phenotypes. A core cognitive trait in EWC appears to be executive dysfunction, with a focus on decision making, response inhibition and cognitive flexibility. Differences between individuals in these areas are likely to contribute to the differences in vulnerability to EWC. The aim of the study was to investigate whether there is a common pattern of executive dysfunction in EWC while comparing anorexia nervosa patients (AN), obese subjects (OB) and healthy eating/weight controls (HC). Methods Thirty five AN patients, fifty two OB and one hundred thirty seven HC were compared using the Wisconsin Card Sorting Test (WCST); Stroop Color and Word Test (SCWT); and Iowa Gambling Task (IGT). All participants were female, aged between 18 and 60 years. Results There was a significant difference in IGT score (F(1.79); p<.001), with AN and OB groups showing the poorest performance compared to HC. On the WCST, AN and OB made significantly more errors than controls (F(25.73); p<.001), and had significantly fewer correct responses (F(2.71); p<.001). Post hoc analysis revealed that the two clinical groups were not significantly different from each other. Finally, OB showed a significant reduced performance in the inhibition response measured with the Stroop test (F(5.11); p<.001) compared with both AN and HC. Conclusions These findings suggest that EWC subjects (namely AN and OB) have similar dysfunctional executive profile that may play a role in the development and maintenance of such disorders.


Diabetes Care | 2012

Hemoglobin A1c Versus Oral Glucose Tolerance Test in Postpartum Diabetes Screening

María José Picón; Mora Murri; Araceli Muñoz; José Carlos Fernández-García; Ricardo Gómez-Huelgas; Francisco J. Tinahones

OBJECTIVE To determine the usefulness of measuring hemoglobin A1c (A1C), alone or combined with the fasting glucose test, compared with the oral glucose tolerance test (OGTT) for the reassessment of the carbohydrate metabolism status in postpartum women with a history of gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS We evaluated the status of carbohydrate metabolism by performing the OGTT and fasting glucose and A1C tests in 231 postpartum women with prior GDM 1 year after delivery. RESULTS The prevalence of abnormal carbohydrate metabolism was 45.89% by the OGTT criterion, 19.05% by the A1C test criterion, 38.10% by the fasting glucose test criterion, and 46.75% by the A1C-fasting glucose test criteria. Using the OGTT as the gold standard, abnormal carbohydrate metabolism according to the A1C test criterion had 22.64% sensitivity and 54.55% positive predictive value; abnormal carbohydrate metabolism by the fasting glucose criterion had 83.02% sensitivity and 100% positive predictive value. The A1C-fasting glucose test criteria classified 18 women with normal carbohydrate metabolism as having abnormal carbohydrate metabolism. Abnormal carbohydrate metabolism by the A1C-fasting glucose test criteria had 83.02% sensitivity and 81.48% positive predictive value. CONCLUSIONS Our results seem to indicate that the A1C test criterion alone or in combination with fasting glucose test criterion does not provide a sensitive and specific diagnosis of abnormal carbohydrate metabolism in women who have had GDM.


International Journal of Endocrinology | 2014

Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index

Maria Pardo; Ana B. Crujeiras; María Amil; Zaida Agüera; Susana Jiménez-Murcia; Rosa M. Baños; Cristina Botella; Rafael de la Torre; Xavier Estivill; Ana B. Fagundo; José Manuel Fernández-Real; José Carlos Fernández-García; Gema Frühbeck; Javier Gómez-Ambrosi; Roser Rodríguez; Francisco J. Tinahones; Fernando Fernández-Aranda; Felipe F. Casanueva

FNDC5/irisin has been recently postulated as beneficial in the treatment of obesity and diabetes because it is induced in muscle by exercise, increasing energy expenditure. However, recent reports have shown that WAT also secretes irisin and that circulating irisin is elevated in obese subjects. The aim of this study was to evaluate irisin levels in conditions of extreme BMI and its correlation with basal metabolism and daily activity. The study involved 145 female patients, including 96 with extreme BMIs (30 anorexic (AN) and 66 obese (OB)) and 49 healthy normal weight (NW). The plasma irisin levels were significantly elevated in the OB patients compared with the AN and NW patients. Irisin also correlated positively with body weight, BMI, and fat mass. The OB patients exhibited the highest REE and higher daily physical activity compared with the AN patients but lower activity compared with the NW patients. The irisin levels were inversely correlated with daily physical activity and directly correlated with REE. Fat mass contributed to most of the variability of the irisin plasma levels independently of the other studied parameters. Conclusion. Irisin levels are influenced by energy expenditure independently of daily physical activity but fat mass is the main contributing factor.


Appetite | 2014

Relationship between eating styles and temperament in an Anorexia Nervosa, Healthy Control, and Morbid Obesity female sample.

Rosa M. Baños; Ausiàs Cebolla; Inés Moragrega; Tatjana van Strien; Fernando Fernández-Aranda; Zaida Agüera; Rafael de la Torre; Felipe F. Casanueva; José Manuel Fernández-Real; José Carlos Fernández-García; Gema Frühbeck; Javier Gómez-Ambrosi; Susana Jiménez-Murcia; Roser Rodríguez; Francisco J. Tinahones; Cristina Botella

OBJECTIVES Eating styles have been studied in both Obesity (OB) and Eating Disorders (ED), but they have not been examined in these two weight conditions together. The present study explores differences in eating styles in an Anorexia Nervosa (AN) and OB sample, compared to Healthy Controls (HC), and it analyses their relationship with Body Mass Index (BMI) and personality traits. METHOD The total sample consisted of 291 female participants (66 AN, 79 OB and 146 HC). EVALUATION Assessment measures included the Dutch Eating Behaviour Questionnaire-DEBQ- and the Temperament and Character Inventory-Revised-TCI-R-. RESULTS The MANCOVA test showed significant differences among the three groups for all eating styles, with emotional eating being more typical in the OB group and restrained eating more typical in the AN group. Partial correlation analyses showed relationships between emotional and external eating and BMI, as well as relationships with different temperament and character traits. The stepwise discriminant function analysis showed that the DEBQ correctly classified 65.6% of the sample into the three weight categories; when combined with the TCI-R, correct classification increased to 72.6%. CONCLUSIONS Weight conditions showed different eating behaviour patterns. Temperament and character traits were related to eating behaviours. DEBQ and TCI-R were able to discriminate between groups. Differences in eating styles in the weight groups can have implications for understanding the development and maintenance of OB and ED.


Journal of Strength and Conditioning Research | 2012

Relationship between muscular strength and sprints with changes of direction.

Alfonso Castillo-Rodríguez; José Carlos Fernández-García; José Luis Chinchilla-Minguet; Elvis A. Carnero

Castillo-Rodríguez, A, Fernandez-García, JC, Chinchilla-Minguet, JL, and Carnero, EÁ. Relationship between muscular strength and sprints with changes of direction. J Strength Cond Res 26(3): 725–732, 2012—Sprints with changes of direction (COD) have been traditionally associated with performance in team sports. Jumping tests have been used as predictors of COD; however, there are not too many studies analyzing how dominance affects the best performance of the turn. The purpose of this study was to explore the relationship between tests pertaining to jumps (1 and 2 legs) and COD (right and left turns). Forty-two male students were selected at the Faculty of Physical Education (age: 20.1 ± 3.7 years; weight: 73.4 ± 8.4 kg; body mass index: 23.1 ± 2.6 kg·m−2; and fat mass: 17.1 ± 8.8%). All the subjects had right leg dominance. The COD tests were assessed using three 10-m sprint tests (90° right and left turns and 180° turn). Jumps were countermovement jumps (CMJs with 1 and 2 legs) and the drop jump (DJ). Pearson coefficient correlation and stepwise regression analyses were performed. Our results showed that both CMJs and DJs were associated with COD. The CMJ with the right leg had the best coefficient correlation with left COD time (r = −0.64; p < 0.01). Also, the CMJ was associated with COD180° time (r = −0.60; p < 0.01). After regression analysis, only right one-leg CMJ and CMJ were predictors of left COD time (adjusted R2 = 0.46; p < 0.01). The main finding of this study was that the CMJ, but not the DJ, was the best predictor of dominant side COD. Jumps are an important component of team sport training because they improve COD performance. However, coaches use several types of jumps during training; our results suggest that jumps similar to the CMJ should be useful tools to improve COD, which helps to specify better training prescription.


The Journal of Clinical Endocrinology and Metabolism | 2015

Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women

Silvia Barja-Fernandez; Cintia Folgueira; Luisa M. Seoane; Felipe F. Casanueva; Carlos Dieguez; Cecilia Castelao; Zaida Agüera; Rosa M. Baños; Cristina Botella; Rafael de la Torre; José Carlos Fernández-García; José Manuel Fernández-Real; Gema Frühbeck; Javier Gómez-Ambrosi; Susana Jiménez-Murcia; Francisco J. Tinahones; Xavier Estivill; Fernando Fernández-Aranda; Ruben Nogueiras

CONTEXT Betatrophin is produced primarily by liver and adipose tissue and has been recently reported as a novel hormone promoting β-cell proliferation and β-cell mass and improving glucose tolerance. OBJECTIVE Because it is markedly regulated by nutritional status, we hypothesized that circulating betatrophin levels might be affected by pathophysiological conditions altering body weight. SETTING AND PATIENTS We analyzed circulating betatrophin levels in 149 female patients, including 99 with extreme body mass index (30 anorexia nervosa, 24 obese, 45 morbid obese, and 50 healthy eating/weight controls). OUTCOME MEASUREMENTS Serum betatrophin levels and its correlations with different anthropometric and biochemical parameters were measured. RESULTS Plasma betatrophin levels were significantly elevated in anorexic patients, whereas its levels were reduced in morbidly obese women when compared with normal-weight women. Plasma betatrophin correlated negatively with weight, body mass index, fat percentage, glucose, insulin, and homeostatic model assessment index and positively correlated with high-density lipoprotein. CONCLUSIONS These results suggest that metabolic status is an important regulator of circulating betatrophin levels.


Clinical Endocrinology | 2014

GLP‐1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects

José Carlos Fernández-García; Mora Murri; Leticia Coín-Aragüez; Juan Alcaide; Rajaa El Bekay; Francisco J. Tinahones

Both glucagon‐like peptide‐1 (GLP‐1) and peptide YY (PYY) are gut hormones involved in energy homoeostasis. Obesity, insulin resistance and hyperglycaemia are significant confounders when GLP‐1 and PYY secretion is assessed. Thus, we evaluated GLP‐1 and PYY response after fat load in morbidly obese patients with different degrees of insulin resistance and glycemic status.


PLOS ONE | 2014

Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament

Fernando Fernández-Aranda; Sarah Sauchelli; Antoni Pastor; Marcela González; Rafael de la Torre; Roser Granero; Susana Jiménez-Murcia; Rosa M. Baños; Cristina Botella; José Manuel Fernández-Real; José Carlos Fernández-García; Gema Frühbeck; Javier Gómez-Ambrosi; Roser Rodríguez; Francisco J. Tinahones; Jon Arcelus; Ana B. Fagundo; Zaida Agüera; Jordi Miró; Felipe F. Casanueva

Background Endocannabinoids and temperament traits have been linked to both physical activity and body mass index (BMI) however no study has explored how these factors interact in females. The aims of this cross-sectional study were to 1) examine differences among distinct BMI groups on daytime physical activity and time spent in moderate-vigorous physical activity (MVPA), temperament traits and plasma endocannabinoid concentrations; and 2) explore the association and interaction between MVPA, temperament, endocannabinoids and BMI. Methods Physical activity was measured with the wrist-worn accelerometer Actiwatch AW7, in a sample of 189 female participants (43 morbid obese, 30 obese, and 116 healthy-weight controls). The Temperament and Character Inventory-Revised questionnaire was used to assess personality traits. BMI was calculated by bioelectrical impedance analysis via the TANITA digital scale. Blood analyses were conducted to measure levels of endocannabinoids and endocannabinoid-related compounds. Path-analysis was performed to examine the association between predictive variables and MVPA. Results Obese groups showed lower MVPA and dysfunctional temperament traits compared to healthy-weight controls. Plasma concentrations of 2-arachidonoylglyceryl (2-AG) were greater in obese groups. Path-analysis identified a direct effect between greater MVPA and low BMI (b = −0.13, p = .039) and high MVPA levels were associated with elevated anandamide (AEA) levels (b = 0.16, p = .049) and N-oleylethanolamide (OEA) levels (b = 0.22, p = .004), as well as high Novelty seeking (b = 0.18, p<.001) and low Harm avoidance (b = −0.16, p<.001). Conclusions Obese individuals showed a distinct temperament profile and circulating endocannabinoids compared to controls. Temperament and endocannabinoids may act as moderators of the low MVPA in obesity.


Current Vascular Pharmacology | 2014

Inflammation, Oxidative Stress and Metabolic Syndrome: Dietary Modulation

José Carlos Fernández-García; Fernando Cardona; Francisco J. Tinahones

The metabolic syndrome (MetS) is a cluster of risk factors for the development of cardiovascular disease and type 2 diabetes mellitus. These risk factors include raised blood pressure, dyslipidemia (raised triglycerides and lowered high-density lipoprotein cholesterol), raised fasting glucose, and central obesity. MetS has become a serious public health and clinical problem whose prevalence and incidence are increasing along with the worldwide rise in rates of obesity and sedentary lifestyles. A number of studies have shown that MetS is associated with a state of low-grade inflammation, characterized by abnormal pro-inflammatory cytokine production, increased acute-phase reactants, and activation of a network of inflammatory signalling pathways. Moreover, MetS has also been linked to oxidative stress, a consequence of a reduction in the antioxidant systems and an increase in the production of reactive oxygen species. Nevertheless, agreement exists that dietary intervention may modulate the pro-inflammatory state and lessen oxidative stress related to MetS, thereby decreasing the cardiovascular risk. In this review we address the current available evidence regarding dietary modulation of inflammation and oxidative stress associated with MetS.


Endocrinología y Nutrición | 2014

Estructura diagnóstica y funcional de una consulta de alta resolución de nódulo tiroideo

José Carlos Fernández-García; Isabel Mancha-Doblas; María Victoria Ortega-Jiménez; José Francisco Ruiz-Escalante; Ignasi Castells-Fusté; Santiago Tofé-Povedano; Iñaki Argüelles-Jiménez; Francisco J. Tinahones

Appearance of a thyroid nodule has become a daily occurrence in clinical practice. Adequate thyroid nodule assessment requires several diagnostic tests and multiple medical appointments, which results in a substantial delay in diagnosis. Implementation of a high-resolution thyroid nodule clinic largely avoids these drawbacks by condensing in a single appointment all tests required for adequate evaluation of thyroid nodule. This paper reviews the diagnostic and functional structure of a high-resolution thyroid nodule clinic.

Collaboration


Dive into the José Carlos Fernández-García's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Felipe F. Casanueva

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zaida Agüera

Instituto de Salud Carlos III

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge